sotatercept
Generic: sotatercept·Brand: Winrevair
sotatercept: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| ACCELERON PHARMA INC (XLRN) | Phase 2 |
Clinical Trials (1)
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)
Frequently asked questions
Who is developing sotatercept?
sotatercept is being developed by ACCELERON PHARMA INC.
How many clinical trials involve sotatercept?
BioSniper tracks 1 clinical trial involving sotatercept.
Get deeper analysis on sotatercept
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis